Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03413917 · ClinicalTrials.gov registry record
Exploration and Determination of Genomic Markers Predictive of Uterine Atony
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 21
- Enrollment target
NCT03413917 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 21 participants.
The verdict
NCT03413917 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether there are markers in the tissue of atonic uteri, and in the patients' plasma that would help identify patients likely to suffer postpartum hemorrhage due to uterine atony. We also will attempt to identify the cause(s) of uterine atony that might suggest mechanisms to prevent and manage it.
Interventions
- OTHER Analysis of genomic markers in uterine atony
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2020-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03413917
The ClinicalTrials.gov registry entry for NCT03413917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Analysis of genomic markers in uterine atony is the first listed.
NCT03413917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03413917 about?
NCT03413917 is a clinical study titled "Exploration and Determination of Genomic Markers Predictive of Uterine Atony". The primary objective of this study is to determine whether there are markers in the tissue of atonic uteri, and in the patients' plasma that would help identify patients likely to suffer postpartum hemorrhage due to uterine atony. We also will attempt to identify the cause(s) of uterine atony that ...
What is the current status of trial NCT03413917?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2018-02-02. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03413917?
The interventions under investigation include: Analysis of genomic markers in uterine atony (OTHER).
Who is sponsoring clinical trial NCT03413917?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.